Z-endoxifen shows promise as new treatment for common breast cancer type

(Mayo Clinic) ROCHESTER, Minn. - Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease. This finding was reported from a clinical trial conducted by researchers at Mayo Clinic and the National Cancer Institute, and published in the Journal of Clinical Oncology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news